Patent · US Active

Antibodies against Clostridium difficile toxins and methods of using the same

US11220537B2 · kind B2 · utility

0Cited by

4References

19Claims

0Family size

Assignee

SANOFI PASTEUR BIOLOGICS, LLC · US

Inventors

Stephen Anderson · Buckshaw Village, GB
Natalie Anosova · Lexington, US
Nicola Beltraminelli · L'Essart Mador, FR
Pierre Garrone · Val-de-Reuil, FR
Harold Kleanthous · Westford, US
Jianxin Zhang · Acton, US
Majid Mehtali · Strasbourg, FR

Key dates

Filing date	Nov 29, 2018
Grant date	Jan 11, 2022
Priority date	—
Expiry date	Nov 29, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Monoclonal antibodies, or antigen-binding fragments thereof, that bind to Clostridium difficile (C. difficile) toxin A or toxin B and methods of using the same to detect or treat C. difficile infections and/or C. difficile-associated disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.